Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
6
×
detroit blog main
detroit top stories
fda
6
×
indiana blog main
indiana top stories
life sciences
merck
6
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
eli lilly
moderna
pfizer
bristol-myers squibb
cancer immunotherapy
glaxosmithkline
roche
startups
abbvie
What
bio
roundup
companies
approved
cancer
drug
fda
growing
life
science
time
week
alliance
annual
arena’s
ash
barcelona
black
bounty
bristol
buy
calls
changing
cig
clinical
color
comeback
conference
continue
corner
crispr
days
deals
debut
december's
deeper
delivered
diamond
diamond’s
digital
Language
unset
Current search:
fda
×
cancer
×
merck
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More